Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Management of Severe Anxiety in Patients on Multiple Psychiatric Medications

Current Medication Regimen Analysis

  • The patient is currently on mirtazapine 15 mg, which is often used for sleep, depression, and anxiety, according to the American Academy of Family Physicians 1
  • Aripiprazole should be increased from 5 mg to 10 mg daily for severe anxiety, as recommended by the American Academy of Child and Adolescent Psychiatry 3
  • The current dose of 5 mg is at the lower end of the therapeutic range, and increasing the dose can help manage anxiety symptoms in bipolar disorder, as suggested by the American Academy of Child and Adolescent Psychiatry 2
  • Aripiprazole has a more favorable side effect profile compared to other antipsychotics, making it a suitable option for patients with bipolar disorder and comorbid anxiety, according to the American Academy of Child and Adolescent Psychiatry 3

Alternative Options

  • Consider adding a benzodiazepine, such as lorazepam 0.5-1 mg orally up to four times daily, for short-term management of severe anxiety symptoms, as recommended by the British Medical Journal 6
  • Reduce the dose to 0.25-0.5 mg in elderly or debilitated patients, as suggested by the British Medical Journal 6

Medication Adjustment

  • Consider increasing mirtazapine from 15 mg to 30 mg at bedtime, as recommended by the American Academy of Family Physicians, to provide better anxiolytic effects 1

Monitoring and Follow-up

  • Monitor for potential side effects of increased aripiprazole dose, including headache, agitation, anxiety, insomnia, dizziness, and drowsiness, as suggested by the American Academy of Child and Adolescent Psychiatry 2
  • Watch for drug interactions, particularly between aripiprazole and other serotonergic agents, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 4, 5
  • Assess response to dose adjustment within 2-4 weeks, as suggested by the Journal of the American Academy of Child and Adolescent Psychiatry 5

Important Considerations and Cautions

  • Avoid adding another SSRI or SNRI due to the risk of serotonin syndrome with the current medication regimen, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 4, 5